Literature DB >> 32625343

Re-evaluation of alginic acid and its sodium, potassium, ammonium and calcium salts (E 400-E 404) as food additives.

Maged Younes, Peter Aggett, Fernando Aguilar, Riccardo Crebelli, Metka Filipič, Maria Jose Frutos, Pierre Galtier, David Gott, Ursula Gundert-Remy, Gunter Georg Kuhnle, Claude Lambré, Jean-Charles Leblanc, Inger Therese Lillegaard, Peter Moldeus, Alicja Mortensen, Agneta Oskarsson, Ivan Stankovic, Ine Waalkens-Berendsen, Rudolf Antonius Woutersen, Matthew Wright, Leon Brimer, Oliver Lindtner, Pasquale Mosesso, Anna Christodoulidou, Zsuzsanna Horváth, Federica Lodi, Birgit Dusemund.   

Abstract

The present opinion deals with the re-evaluation of alginic acid and its sodium, potassium, ammonium and calcium salts (E 400-E 404) when used as food additives. Alginic acid and its salts (E 400-E 404) are authorised food additives in the EU in accordance with Annex II and Annex III to Regulation (EC) No 1333/2008. Following the conceptual framework for the risk assessment of certain food additives re-evaluated under Commission Regulation (EU) No 257/2010, the Panel concluded that there was no need for a numerical Acceptable Daily Intake (ADI) for alginic acid and its salts (E 400, E 401, E 402, E 403 and E 404), and that there was no safety concern at the level of the refined exposure assessment for the reported uses of alginic acid and its salts (E 400, E 401, E 402, E 403 and E 404) as food additives. The Panel further concluded that exposure of infants and young children to alginic acid and its salts (E 400, E 401, E 402, E 403 and E 404) by the use of these food additives should stay below therapeutic dosages for these population groups at which side-effects could occur. Concerning the use of alginic acid and its salts (E 400, E 401, E 402, E 403 and E 404) in 'dietary foods for special medical purposes and special formulae for infants' (Food category 13.1.5.1) and 'in dietary foods for babies and young children for special medical purposes as defined in Directive 1999/21/EC' (Food category 13.1.5.2), the Panel further concluded that the available data did not allow an adequate assessment of the safety of alginic acid and its salts (E 400, E 401, E 402, E 403 and E 404) in infants and young children consuming the food belonging to the categories 13.1.5.1 and 13.1.5.2.
© 2017 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.

Entities:  

Keywords:  alginic acid (E 400); ammonium alginate (E 403); calcium alginate (E 404); food additives.; potassium alginate (E 402); sodium alginate (E 401)

Year:  2017        PMID: 32625343      PMCID: PMC7010146          DOI: 10.2903/j.efsa.2017.5049

Source DB:  PubMed          Journal:  EFSA J        ISSN: 1831-4732


  7 in total

Review 1.  Aquaculture Production of the Brown Seaweeds Laminaria digitata and Macrocystis pyrifera: Applications in Food and Pharmaceuticals.

Authors:  Diane Purcell-Meyerink; Michael A Packer; Thomas T Wheeler; Maria Hayes
Journal:  Molecules       Date:  2021-02-28       Impact factor: 4.411

2.  Safety and efficacy of a feed additive consisting of sodium alginate for all animal species (ALGAIA).

Authors:  Vasileios Bampidis; Giovanna Azimonti; Maria de Lourdes Bastos; Henrik Christensen; Birgit Dusemund; Mojca Fašmon Durjava; Maryline Kouba; Marta López-Alonso; Secundino López Puente; Francesca Marcon; Baltasar Mayo; Alena Pechová; Mariana Petkova; Fernando Ramos; Yolanda Sanz; Roberto Edoardo Villa; Ruud Woutersen; Rosella Brozzi; Jaume Galobart; Lucilla Gregoretti; Maria Vittoria Vettori; Matteo Lorenzo Innocenti
Journal:  EFSA J       Date:  2022-03-07

Review 3.  Approaches in Animal Proteins and Natural Polysaccharides Application for Food Packaging: Edible Film Production and Quality Estimation.

Authors:  Andrey Lisitsyn; Anastasia Semenova; Viktoria Nasonova; Ekaterina Polishchuk; Natalia Revutskaya; Ivan Kozyrev; Elena Kotenkova
Journal:  Polymers (Basel)       Date:  2021-05-15       Impact factor: 4.329

Review 4.  Alginate and alginate composites for biomedical applications.

Authors:  Raha Ahmad Raus; Wan Mohd Fazli Wan Nawawi; Ricca Rahman Nasaruddin
Journal:  Asian J Pharm Sci       Date:  2020-11-05       Impact factor: 6.598

5.  Design and Optimization of a Self-Assembling Complex Based on Microencapsulated Calcium Alginate and Glutathione (CAG) Using Response Surface Methodology.

Authors:  Ricardo I Castro; Luis Morales-Quintana; Nancy Alvarado; Luis Guzmán; Oscar Forero-Doria; Felipe Valenzuela-Riffo; V Felipe Laurie
Journal:  Polymers (Basel)       Date:  2021-06-24       Impact factor: 4.329

6.  Preparation of Beebread Caviar from Buckwheat Honey through Immobilization with Sodium Alginate.

Authors:  Małgorzata Smuga-Kogut; Agnieszka Pabiszczak; Maria Dymkowska-Malesa; Daria Szymanowska; Joanna Kobus-Cisowska; Judyta Cielecka-Piontek
Journal:  Molecules       Date:  2020-09-29       Impact factor: 4.411

7.  On the Health Benefits vs. Risks of Seaweeds and Their Constituents: The Curious Case of the Polymer Paradigm.

Authors:  João Cotas; Diana Pacheco; Glacio Souza Araujo; Ana Valado; Alan T Critchley; Leonel Pereira
Journal:  Mar Drugs       Date:  2021-03-19       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.